Received Jan 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | TD2FD | IM / LA |
Seven days post vaccination developed painful pink/purple lesions under right breast. Lesions became more painful and numerous, sought medical intervention late May 2024, diagnosed with Hidradenitis Suppurativa. Condition remains chronic and painful. Treating dermatologist and primary care provider both explained that Tdap triggered condition.
Sulfa